Healthcare Blogs and Articles

Your Insurance Said No? Here's How to Win the Appeal #CareTalk
BlogMar 2, 2026

Your Insurance Said No? Here's How to Win the Appeal #CareTalk

The latest #CareTalk episode highlights free AI tools that help patients draft professional appeal letters after insurance denials. Counterforce Health demonstrates how these tools can address prior authorization refusals, claim rejections, and claims of non‑medical necessity. Guests Diane Archer and...

By Laura Packard
Bysanti FDA Approval for Bipolar I and Schizophrenia Marks Vanda’s Second Win in Two Months
BlogMar 2, 2026

Bysanti FDA Approval for Bipolar I and Schizophrenia Marks Vanda’s Second Win in Two Months

Vanda Pharmaceuticals received FDA approval for Bysanti (milsaperidone) to treat acute manic or mixed episodes of bipolar I disorder and schizophrenia in adults. The approval introduces a new chemical entity in the atypical antipsychotic class that is bioequivalent to Vanda’s...

By Xtalks – Biotech Blogs
Pharma Pulse: Regulatory Speed Records
BlogMar 2, 2026

Pharma Pulse: Regulatory Speed Records

Boehringer Ingelheim’s oral kinase inhibitor Hernexeos received FDA accelerated approval for first‑line HER2‑mutant lung cancer in a record‑fast 44 days, thanks to the National Priority Voucher program. The drug demonstrated a 76 % response rate, positioning it as a breakthrough in personalized...

By Pharmaceutical Commerce (independent trade)
Rethinking Idiopathic Pulmonary Fibrosis: Unmet Needs, Evolving Biology and the Future of Clinical Research
BlogMar 2, 2026

Rethinking Idiopathic Pulmonary Fibrosis: Unmet Needs, Evolving Biology and the Future of Clinical Research

Idiopathic pulmonary fibrosis (IPF) continues to pose a severe, often late‑diagnosed respiratory challenge, with mortality exceeding many cancers. Boehringer Ingelheim’s Martin Beck highlighted the shift toward earlier detection using AI‑enhanced imaging and a broader view of IPF as a heterogeneous,...

By Xtalks – Biotech Blogs
New Deductible Rules Allow for $31,000 Out-of-Pocket Maximum
BlogMar 2, 2026

New Deductible Rules Allow for $31,000 Out-of-Pocket Maximum

The Trump administration is proposing a rule that revives catastrophic, or "junk," health plans with a $31,000 family deductible, effectively undoing the ACA’s ban on such high‑deductible products. These plans, once sold by major insurers like Cigna, Aetna and UnitedHealthcare,...

By HEALTH CARE un-covered
INN-Coming: Insights on the Industry’s Latest Disclosures
BlogMar 2, 2026

INN-Coming: Insights on the Industry’s Latest Disclosures

The WHO’s INN proposed list 134, released in early 2026, reveals several late‑stage drug candidates that were previously hidden from public view. Notably, two NLRP3 inhibitors—abdenoflast and parunoflast—appear to map to Eli Lilly’s newly acquired Ventyx assets VTX2735 and VTX3232, both showing promising...

By Drug Hunter
Why One Iowa-Based Company Opened a Primary Care Clinic Near Its Office
BlogMar 2, 2026

Why One Iowa-Based Company Opened a Primary Care Clinic Near Its Office

Pella Corporation opened a wellness center five minutes from its Iowa headquarters, offering primary care, behavioral health, and pharmacy services to its 2,500 employees. The clinic was built in partnership with Premise Health, which designed a high‑touch, high‑tech model that...

By HR Brew
Why I Stopped Accepting Pharmaceutical-Sponsored Lunches
BlogMar 2, 2026

Why I Stopped Accepting Pharmaceutical-Sponsored Lunches

Timothy Lesaca, a psychiatrist, stopped accepting pharmaceutical‑sponsored lunches, arguing they blur the line between patient care and industry influence. Recent CMS Open Payments data reveal over 1.1 million industry events in 2024, with 920 000 lunches costing $73 million. Research shows even a...

By KevinMD
Article Intro - SurgRAW: Multi-Agent Workflow  for Robotic Surgical Video Analysis
BlogMar 2, 2026

Article Intro - SurgRAW: Multi-Agent Workflow for Robotic Surgical Video Analysis

IEEE Robotics and Automation Letters introduces SurgRAW, a multi‑agent, chain‑of‑thought workflow designed for zero‑shot reasoning on robotic surgical video. The system builds on SurgCoTBench, a new benchmark with 14,256 question‑answer pairs and frame‑level annotations across five core surgical tasks. By...

By SurgRob
Best Practices for Applying HDX-MS to FBLD
BlogMar 2, 2026

Best Practices for Applying HDX-MS to FBLD

A recent open‑access study demonstrates that hydrogen‑deuterium exchange mass spectrometry (HDX‑MS) can reliably map binding sites of extremely weak fragment hits (up to 7 mM KD) against Cyclophilin D. By optimizing protein concentration at 10 µM and testing fragments at 2.5‑10 mM, the...

By Practical Fragments
Alcidion Delivering ‘Software as a Medical Device’ AI Capabilities in Both Australia and the UK
BlogMar 2, 2026

Alcidion Delivering ‘Software as a Medical Device’ AI Capabilities in Both Australia and the UK

Alcidion announced that its Miya Precision Concept Detection AI feature has achieved Class 1 medical device registration on Australia’s ARTG (ID 522634) and the UK’s MHRA. The tool parses clinicians’ free‑text notes, proposes SNOMED CT codes and streamlines documentation while requiring clinician validation....

By Health Tech World
You Don’t Notice Public Health Until It’s Gone: The True Costs of Cutting the Workforce - Voices #29
BlogMar 2, 2026

You Don’t Notice Public Health Until It’s Gone: The True Costs of Cutting the Workforce - Voices #29

Emma Aston, a former CDC health communicator, details how a 2025 Reduction in Force eliminated roughly a quarter of the agency’s workforce, silencing key public‑health messaging. The cuts halted campaigns on tobacco, HIV, and flu, while new executive orders imposed...

By The Public Health Workforce is Not OK
Gene Therapy’s Inflexion Point: From Scientific Breakthrough to Systemic Transformation
BlogMar 2, 2026

Gene Therapy’s Inflexion Point: From Scientific Breakthrough to Systemic Transformation

Gene therapy for sickle cell disease has moved from experimental promise to an actionable clinical reality, with early CRISPR‑based treatments already cutting crises and hospital stays. A recent Sanius Health survey of 94 patients shows strong interest—71% want more information—yet...

By Health Tech World
Philosophy in Medicine: Why Doctors Need to Ask “Why”
BlogMar 2, 2026

Philosophy in Medicine: Why Doctors Need to Ask “Why”

An EMT recounts a harrowing transport of a stroke‑survivor, Molly, highlighting how standard stair‑chair equipment failed to accommodate her size and mobility limitations, leading to injury and indignity. The author uses the incident to illustrate structural violence and the marginalization...

By KevinMD
DHSC Launches Industry Readiness Survey on Value Based Procurement
BlogMar 2, 2026

DHSC Launches Industry Readiness Survey on Value Based Procurement

The UK Department of Health and Social Care (DHSC) has launched an industry‑readiness survey on Value Based Procurement (VBP), targeting MedTech and health‑technology firms. The ten‑minute questionnaire seeks a single consolidated response per company and must be submitted by 27 March....

By Med-Tech Insights
HDRS Appointment Is Moment to Create Momentum
BlogMar 2, 2026

HDRS Appointment Is Moment to Create Momentum

The UK Health Data Research Service (HDRS) is set to launch later this year as a secure, single gateway for national health and care datasets, aiming to unlock the country’s extensive longitudinal records. The government announced Melanie Ivarsson, a former...

By Med-Tech Insights
Changes in the Gut Microbiome Drive Age-Related Intestinal Barrier Dysfunction
BlogMar 2, 2026

Changes in the Gut Microbiome Drive Age-Related Intestinal Barrier Dysfunction

Researchers identified that the aging gut microbiome harbors increased Klebsiella aerogenes, which elevates histamine production and compromises intestinal barrier integrity. The excess histamine suppresses Nlrp6 expression, disrupting LC3‑mediated autophagy and intensifying inflammation in septic models. Experiments showed that lowering histamine...

By Fight Aging!
Real-World Data Brings New Insights to Natural History of Disease Studies
BlogMar 2, 2026

Real-World Data Brings New Insights to Natural History of Disease Studies

Real‑world data (RWD) is reshaping natural history studies by delivering longitudinal, patient‑level information that was previously only obtainable through costly prospective trials. Advances in artificial intelligence and natural language processing now allow rapid extraction of structured data from unstructured sources...

By Pharmaceutical Executive (independent trade outlet)
Medimaps Group and Radiobotics Announce Strategic Merger to Expand AI-Driven Musculoskeletal Imaging Portfolio
BlogMar 2, 2026

Medimaps Group and Radiobotics Announce Strategic Merger to Expand AI-Driven Musculoskeletal Imaging Portfolio

Medimaps Group and Radiobotics have agreed to merge, forming a global AI‑driven musculoskeletal imaging company. The combined entity will deliver an end‑to‑end suite across X‑ray and DXA, including automated fracture detection, opportunistic bone fragility assessment, and fracture‑risk prediction. It will...

By HealthTech HotSpot
LM PAEK Can Outperforms PEEK In Certain Applications
BlogMar 2, 2026

LM PAEK Can Outperforms PEEK In Certain Applications

A Drexel‑led study demonstrated that low‑melt polyaryletherketone (LM PAEK) can be fused‑filament‑fabricated into porous knee‑revision cones that outperform traditional PEEK in shear strength and stiffness. Using a Taguchi L8 design, the researchers printed 64 cylindrical surrogates with gyroid and diamond TPMS...

By Fabbaloo
Harnessing Technology to Redefine Standards in GI Care
BlogMar 2, 2026

Harnessing Technology to Redefine Standards in GI Care

Gifthealth’s co‑founder John Romano outlines how AI‑driven pricing tools and automated patient‑support platforms can lower out‑of‑pocket costs and improve medication adherence for the 60 million Americans living with gastrointestinal diseases. By integrating real‑time claims adjudication, discount automation and personalized education, the...

By Health Tech World
Driving Innovation in Medical Motion Control
BlogMar 2, 2026

Driving Innovation in Medical Motion Control

Motion control underpins modern medical devices such as surgical robots, imaging systems, and laboratory instruments, yet it remains a complex engineering hurdle. Dave Beckstoffer of Portescap highlights how early, collaborative partnerships with motion‑control specialists can streamline development and boost reliability....

By Med-Tech Insights
PHTI Breaks Down Barriers to Clinical AI
BlogMar 2, 2026

PHTI Breaks Down Barriers to Clinical AI

The Patient‑Centered Health Technology Initiative (PHTI) released a Clinical AI report built from a workshop with senior leaders across health systems, insurers, tech firms, and federal agencies. Participants identified policy, reimbursement, and evidence gaps as primary barriers to scaling AI...

By Digital Health Wire
Otsuka Medical Devices/Otsuka Pharmaceutical: Paradise Ultrasound Renal Denervation System for the Treatment of Resistant Hypertension, Now Covered by Insurance and...
BlogMar 2, 2026

Otsuka Medical Devices/Otsuka Pharmaceutical: Paradise Ultrasound Renal Denervation System for the Treatment of Resistant Hypertension, Now Covered by Insurance and...

Otsuka Medical Devices and Otsuka Pharmaceutical announced that Japan’s National Health Insurance will cover the Paradise™ Ultrasound Renal Denervation (uRDN) system starting March 1, with commercial sales beginning March 2. The device, developed by Recor Medical, targets resistant‑hypertension patients who remain uncontrolled...

By HealthTech HotSpot
What Chess Taught Me About Clinical Reasoning and Humanism
BlogMar 1, 2026

What Chess Taught Me About Clinical Reasoning and Humanism

Medical students Jay Pendyala and Jonathan Berg compare chess strategy to clinical reasoning, highlighting how assessing a patient mirrors evaluating a board position. They argue that diagnostic algorithms serve as openings, but flexibility is required when cases deviate from textbook...

By KevinMD
Physician Free Speech Rights Under Fire: The DOJ Vs. Patient Education
BlogMar 1, 2026

Physician Free Speech Rights Under Fire: The DOJ Vs. Patient Education

The Department of Justice is appealing a ruling that blocked a subpoena targeting a queer‑owned clinic providing gender‑affirming care, arguing that the clinic’s patient‑education materials should be treated as drug labeling under the Federal Food, Drug, and Cosmetic Act. By...

By KevinMD
Treating Methamphetamine-Associated Dental Disease in Safety-Net Clinics
BlogMar 1, 2026

Treating Methamphetamine-Associated Dental Disease in Safety-Net Clinics

Dr. Charan Teja Bobba recounts treating a patient with meth‑associated dental disease in a MassHealth safety‑net clinic. Methamphetamine caused extensive enamel loss, xerostomia, and rapid decay, demanding complex restorative procedures over several visits. By involving the patient in every step and building...

By KevinMD
Reproductive Care for Rare Diseases: The Missing Playbook
BlogMar 1, 2026

Reproductive Care for Rare Diseases: The Missing Playbook

Lymphangioleiomyomatosis (LAM), a rare estrogen‑sensitive lung disease, highlights the absence of standardized reproductive care for women with rare conditions. While FDA‑approved therapies have extended patients' lives, guidance on pregnancy, contraception, and menopause remains fragmented. The author’s personal journey—freezing embryos and...

By KevinMD
Industry Report: Healthcare Q1 2026 [Peakstone]
BlogMar 1, 2026

Industry Report: Healthcare Q1 2026 [Peakstone]

Healthcare M&A activity moderated in 2025, dropping to 898 transactions after a pandemic‑driven surge. Despite fewer deals, the median transaction value jumped to $151 million, the highest in 25 years, while EV/EBITDA multiples held steady near 12.5×. Public‑market returns diverged, with...

By Axial Forum
The Myth of Cancer Overdiagnosis: Why Screening Saves Lives
BlogMar 1, 2026

The Myth of Cancer Overdiagnosis: Why Screening Saves Lives

A new commentary challenges the notion that cancer overdiagnosis undermines screening, arguing that population‑wide programs have consistently reduced mortality for the five most screened cancers. Critics point to rising incidence without proportional mortality as evidence of overdiagnosis, yet recent trial...

By KevinMD
Early-Stage Medical Device Innovation: How to Discuss Untested Ideas
BlogMar 1, 2026

Early-Stage Medical Device Innovation: How to Discuss Untested Ideas

The article argues that early‑stage medical device ideas require a balanced communication approach that avoids both silence and hype. It highlights the tension trainees and researchers feel when sharing untested concepts and proposes focusing discussions on problems, trade‑offs, and unknowns...

By KevinMD Tech
The AI Medical Services Act: What It Gets Right, Where It Falls Short, and Why It Matters for the Next...
BlogMar 1, 2026

The AI Medical Services Act: What It Gets Right, Where It Falls Short, and Why It Matters for the Next...

The AI Medical Services Act (AMSA) creates a new licensure category for AI-driven clinical tools, mandating tiered risk oversight, physician supervision, and a regulatory sandbox for limited deployments. It embeds bias monitoring, adverse‑event reporting, and a framework for Medicaid and...

By Thoughts on Healthcare Markets & Tech
Weekly Reads: Longevity Hype Vs. Cool Research, Losing Your Y, FDA Maelstrom
BlogMar 1, 2026

Weekly Reads: Longevity Hype Vs. Cool Research, Losing Your Y, FDA Maelstrom

This week’s coverage juxtaposes longevity hype with emerging science, highlighting David Sinclair’s bold claim that aging could be reversed within 10‑20 years, a new Nature paper confirming adult hippocampal neurogenesis, and research showing men lose the Y chromosome as they...

By The Niche
Primary Care Receives only Five Cents of Every Health Care Dollar [PODCAST]
BlogMar 1, 2026

Primary Care Receives only Five Cents of Every Health Care Dollar [PODCAST]

The KevinMD podcast features family physician Jonathan Bushman highlighting that primary care receives only about five percent of total health‑care spending while addressing roughly ninety percent of patient health issues. Bushman contrasts the modest financial return for primary‑care physicians with...

By KevinMD
Rural Maternity Care in Crisis: 5 Solutions to Save Local OB Units
BlogFeb 28, 2026

Rural Maternity Care in Crisis: 5 Solutions to Save Local OB Units

Rural maternity care across the United States is collapsing as hospitals shutter labor and delivery units, leaving many counties without obstetric services. The article identifies five actionable solutions: expanding cross‑trained clinician workforces, implementing obstetric‑ready nursing models, forging collaborative transfer networks,...

By KevinMD
Epic's First Pharma Deal
BlogFeb 28, 2026

Epic's First Pharma Deal

Epic Systems announced its first pharmaceutical customer, Eli Lilly, for the newly launched Epic Discovery platform. The deal marks the inaugural sale of a Health Grid product to a life‑sciences firm, allowing Lilly to streamline clinical trial creation, site identification, activation,...

By Health API Guy
Does Lowering Cholesterol Harm the Brain?
BlogFeb 28, 2026

Does Lowering Cholesterol Harm the Brain?

The brain houses about 20‑25% of the body’s cholesterol, yet it relies on local synthesis because circulating cholesterol cannot cross the blood‑brain barrier. Although some patients report transient brain fog on statins, large observational studies generally show neutral or even...

By The Peter Attia Drive / Articles
GSMA Foundry, NUHS Partner to Drive 5G and AI Innovations in Healthcare
BlogFeb 28, 2026

GSMA Foundry, NUHS Partner to Drive 5G and AI Innovations in Healthcare

The GSMA announced a strategic partnership between its Foundry innovation hub and Singapore’s National University Health System (NUHS) to accelerate 5G‑enabled, AI‑driven healthcare solutions. The collaboration will focus on private 5G networks, digital twins, XR, IoT and ambient AI to...

By TelecomDrive
RevolutionEHR Launches RevPay, Redefining How Optometry Practices Manage Cash Flow
BlogFeb 27, 2026

RevolutionEHR Launches RevPay, Redefining How Optometry Practices Manage Cash Flow

RevolutionEHR introduced RevPay, an embedded payments solution that integrates checkout, patient records, and reporting within its AI‑native platform. The tool supports card, ACH, digital wallets and offers optional patient surcharging, promising to reduce processing fees that can cost $10,000‑$18,000 annually...

By HealthTech HotSpot
Cybersecurity and AI in the Era of Home-Based Care Logistics
BlogFeb 27, 2026

Cybersecurity and AI in the Era of Home-Based Care Logistics

Kenco’s vice‑president of life sciences, Tim McClatchy, detailed how the firm is hardening cybersecurity across its manufacturer‑to‑home delivery network while deploying AI to streamline labor planning and route optimization. He explained the specific encryption and verification steps used at each...

By Pharmaceutical Commerce (independent trade)
Median Technologies to Present at the TD Cowen 46th Annual Health Care Conference
BlogFeb 27, 2026

Median Technologies to Present at the TD Cowen 46th Annual Health Care Conference

Median Technologies announced it will present at TD Cowen’s 46th Annual Health Care Conference in Boston from March 2‑4, 2026. CEO Fredrik Brag will discuss the company’s latest AI‑driven SaMD developments and upcoming milestones on March 4 at 11:10 am ET. The presentation will be...

By HealthTech HotSpot
Pharmaceutical Executive Daily: FDA Approves Hernexeos
BlogFeb 27, 2026

Pharmaceutical Executive Daily: FDA Approves Hernexeos

The FDA approved Hernexeos through the national priority voucher program, a mechanism that fast‑tracks drugs addressing unmet medical needs. Industry leaders are evaluating direct‑to‑consumer (DTC) models to broaden access to HIV prevention tools, leveraging digital and telehealth channels. Additionally, the...

By Pharmaceutical Executive (independent trade outlet)
A Tale of Three Bispecific Cities
BlogFeb 27, 2026

A Tale of Three Bispecific Cities

Three bispecific antibodies targeting PD‑1 and CTLA‑4—lorigerlimab, volrustomig, and cadonilimab—illustrate divergent engineering strategies. Lorig erlimab relies on a knob‑into‑hole heterodimer, volrustomig adopts a common light chain format, and cadonilimab incorporates Fc‑silencing mutations. Their distinct designs have produced markedly different safety...

By Biotech Strategy Blog
CFG Health Launches CareLink™ — A Fully Integrated, 24/7 Telehealth Platform for Correctional Health Care
BlogFeb 27, 2026

CFG Health Launches CareLink™ — A Fully Integrated, 24/7 Telehealth Platform for Correctional Health Care

CFG Health launched CareLink, a proprietary 24/7 telehealth platform designed for correctional facilities. Built on existing security‑issued tablets, the solution delivers emergency triage, primary, behavioral, and specialty care while maintaining HIPAA compliance. The platform combines CFG’s in‑house clinicians with external...

By HealthTech HotSpot
Acupath Laboratories, Inc. Partners with Azer Scientific to Install the First AzerView Digital Pathology Scanner in the United States
BlogFeb 27, 2026

Acupath Laboratories, Inc. Partners with Azer Scientific to Install the First AzerView Digital Pathology Scanner in the United States

Acupath Laboratories has partnered with Azer Scientific to install the first AzerView LH510 digital pathology scanner in the United States. The LH510 offers high‑resolution whole‑slide imaging and streamlined workflow features designed for clinical, academic, and reference labs. The installation marks...

By HealthTech HotSpot
Shining the Light on Shadow Bundles
BlogFeb 27, 2026

Shining the Light on Shadow Bundles

In February 2024 CMS unveiled “shadow bundles,” a modified BPCI‑A methodology that collects episode cost and quality data for hospitals and specialists without their explicit participation. The information is shared primarily with ACOs, MSSP participants, Medicare Advantage plans, and large...

By The Surgeon’s Record
FAQ: Inflation Reduction Act and Medicare Drug Pricing
BlogFeb 27, 2026

FAQ: Inflation Reduction Act and Medicare Drug Pricing

The Inflation Reduction Act reshapes Medicare Part D by granting CMS authority to negotiate prices for high‑cost drugs and instituting a $2,100 annual out‑of‑pocket cap for beneficiaries starting this year. The first ten drugs, including Ozempic and Wegovy, will have negotiated...

By Pharmaceutical Commerce (independent trade)
Beyond BMI: Why Weight Management Must Look Inside the Body
BlogFeb 27, 2026

Beyond BMI: Why Weight Management Must Look Inside the Body

Recent research highlights that BMI alone misclassifies up to 34% of adults, masking critical changes in muscle mass and fluid balance. Rapid weight loss driven by GLP‑1 therapies can cause substantial muscle and intracellular water loss while extracellular fluid rises,...

By KevinMD
Learned Helplessness and Self-Efficacy in Tobacco Treatment
BlogFeb 27, 2026

Learned Helplessness and Self-Efficacy in Tobacco Treatment

The article explains how repeated failed quit attempts create learned helplessness among smokers, undermining their belief that effort matters. It contrasts this with self‑efficacy, a task‑specific confidence that predicts successful cessation. Pharmacotherapy combined with structured counseling can double quit rates,...

By KevinMD